DK1251853T3 - Transdermalt terapeutisk system til indgivelse af zaleplon - Google Patents

Transdermalt terapeutisk system til indgivelse af zaleplon

Info

Publication number
DK1251853T3
DK1251853T3 DK01902334T DK01902334T DK1251853T3 DK 1251853 T3 DK1251853 T3 DK 1251853T3 DK 01902334 T DK01902334 T DK 01902334T DK 01902334 T DK01902334 T DK 01902334T DK 1251853 T3 DK1251853 T3 DK 1251853T3
Authority
DK
Denmark
Prior art keywords
tts
zaleplon
therapeutic system
transdermal therapeutic
administration
Prior art date
Application number
DK01902334T
Other languages
English (en)
Inventor
Thorsten Selzer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK1251853T3 publication Critical patent/DK1251853T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK01902334T 2000-02-01 2001-01-18 Transdermalt terapeutisk system til indgivelse af zaleplon DK1251853T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10004790A DE10004790B4 (de) 2000-02-01 2000-02-01 Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
PCT/EP2001/000532 WO2001056576A1 (de) 2000-02-01 2001-01-18 Transdermales therapeutisches system zur verabreichung von zaleplon

Publications (1)

Publication Number Publication Date
DK1251853T3 true DK1251853T3 (da) 2004-02-16

Family

ID=7629739

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01902334T DK1251853T3 (da) 2000-02-01 2001-01-18 Transdermalt terapeutisk system til indgivelse af zaleplon

Country Status (10)

Country Link
US (1) US20030013726A1 (da)
EP (1) EP1251853B1 (da)
JP (1) JP2003525224A (da)
KR (1) KR100610624B1 (da)
AT (1) ATE252904T1 (da)
AU (1) AU2001230193A1 (da)
DE (2) DE10004790B4 (da)
DK (1) DK1251853T3 (da)
ES (1) ES2210122T3 (da)
WO (1) WO2001056576A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160076A0 (en) 2001-08-01 2004-06-20 Biogal Gyogyszergyar Process for purifying n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
WO2003068238A1 (en) * 2002-02-15 2003-08-21 Biogal Gyogyszergyar Rt. Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
CN100402036C (zh) * 2004-04-26 2008-07-16 袁重华 治疗失眠的涂敷剂
CN1306934C (zh) * 2004-09-29 2007-03-28 中国人民解放军军事医学科学院基础医学研究所 一种含有扎莱普隆的药物组合物及制备方法
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
LT2276473T (lt) 2008-04-18 2017-02-27 Intec Pharma Ltd. Pailginto atpalaidavimo vaistų karbidopa/levodopa įvedimas
WO2010045615A2 (en) * 2008-10-16 2010-04-22 Cenomed Biosciences, Llc Treatment of organophosphate exposure with ocinaplon
EP2378883B1 (en) 2008-12-04 2015-12-23 Intec Pharma Ltd. Zaleplon gastroretentive drug delivery system
US9522595B2 (en) * 2011-01-27 2016-12-20 Irobot Defense Holdings, Inc. Small unmanned ground vehicle
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
ATE97414T1 (de) * 1985-05-13 1993-12-15 American Cyanamid Co (7-(3-disubstituierte amino)phenyl>pyrazolo(1,5- a>-pyrimidine.
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
AU660336B2 (en) * 1991-10-18 1995-06-22 Alza Corporation Device for the transdermal administration of melatonin
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung
JPH09136835A (ja) * 1995-11-14 1997-05-27 Sekisui Chem Co Ltd 経皮吸収貼付剤
SE9504537D0 (sv) * 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
JPH09278651A (ja) * 1996-04-05 1997-10-28 Sekisui Chem Co Ltd 経皮吸収貼付剤
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
JPH11228414A (ja) * 1998-02-06 1999-08-24 Sumitomo Pharmaceut Co Ltd タンドスピロン経皮剤
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto

Also Published As

Publication number Publication date
AU2001230193A1 (en) 2001-08-14
DE50100870D1 (de) 2003-12-04
ATE252904T1 (de) 2003-11-15
ES2210122T3 (es) 2004-07-01
US20030013726A1 (en) 2003-01-16
WO2001056576A1 (de) 2001-08-09
DE10004790A1 (de) 2001-08-09
EP1251853A1 (de) 2002-10-30
DE10004790B4 (de) 2004-09-09
EP1251853B1 (de) 2003-10-29
JP2003525224A (ja) 2003-08-26
KR100610624B1 (ko) 2006-08-09
KR20020079819A (ko) 2002-10-19

Similar Documents

Publication Publication Date Title
DE50112720D1 (de) Transdermales therapeutisches system mit hochdispersem siliziumdioxid
DK0674913T3 (da) Ikke-okklusivt klæbende plaster til påföring af medicament i huden
NO20050472L (no) Forbedret transdermalt leveringssystem for administrering av rotigotin
GEP20084561B (en) System and method for controlled drug release and transdermal drug delivery device
ATE216240T1 (de) Transdermales therapeutisches system mit galanthamin als wirksamen bestandteil
PT91327A (pt) Emplastro de varias camadas
ATE313320T1 (de) Strukturen und verfahren zur verabreichung von cannabis an patienten
IE800059L (en) Polymeric diffusion matrix
DE69923348D1 (de) Transdermales arzneistoffverabreichungssystem
DK1251853T3 (da) Transdermalt terapeutisk system til indgivelse af zaleplon
ES2118249T3 (es) Parche que contiene dexpanthenol para la aplicacion percutanea de hormonas esteroideas.
ATE396714T1 (de) Transdermales therapeutisches system mit verbessertem langzeittragekomfort
MXPA02009103A (es) Sistema terapeutico transdermal para la administracion de lerisetron.
DE60309329D1 (de) Verbessertes transdermales abgabesystem
PT1011674E (pt) Sistema terapeutico transdermico com a substancia activa escopolamina base
NO952908L (no) Nitroglycerolholdig plaster, fremgangsmåte for fremstilling, samt anvendelse av plasteret
BRPI0011135B8 (pt) sistema de ministração terapêutica transdérmica contendo agente neuroléptico
AR022956A1 (es) Sistema transdermal terapeutico y procedimiento para su fabricacion